Legal & General Group
RXDX

Legal & General Group’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Legal & General Group’s Portfolio RXDX Stock Details RXDX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
2023
Q1 		$2.96M Buy
2022
Q4 		$1.12M Buy
2022
Q3 		$358K Buy
2022
Q2 		$158K Buy
2022
Q1 		$197K Sell
2021
Q4 		$241K Buy
2021
Q3 		$23K Buy
2021
Q2 		$22K Buy